On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster ...

HIMS accelerates its global push with the ZAVA acquisition and a planned Canada launch targeting affordable obesity care.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Hims & Hers Health recurring revenue grew 111% YoY, boosted by personalization and chronic care. Forecasting $2.35B revenue ...

The company will offer a generic version of semaglutide in the country after Novo Nordisk let its patent expire there. Hims & ...

Hims & Hers (HIMS) stock in focus as the company faces a growing number of lawsuits following Novo Nordisk's (NVO) decision ...

Coca‑Cola has announced that it will launch a new version of its iconic Coke in the U.S. this autumn, sweetened with ...

XOOX is turning backpacks into portable entertainment hubs, while CyFireAI helps small businesses stay ahead of cyber threats ...

Key Points It isn't easy finding high-yield dividend growth stocks when the market is at an all-time high.Shares of Novo ...

In the latest trading session, VICI Properties Inc. (VICI) closed at $33.45, marking a +2.14% move from the previous day. The ...

Canadian National (CNI) reported $3.09 billion in revenue for the quarter ended June 2025, representing a year-over-year decline of 2.4%. EPS of $1.35 for the same period compares to $1.35 a year ...

We can't have it both ways. If we want more cutting-edge drugs, we have to protect the property rights that make them ...